What is The Beauty Health Company's revenue?

The Beauty Health Company (SKIN) generated $296.1M in revenue over the trailing twelve months, down 8.2% year over year.

Is The Beauty Health Company profitable?

The Beauty Health Company is not currently profitable: it reported a net loss of $6.1M over the trailing twelve months, a -2.0% net margin.

What are The Beauty Health Company's profit margins?

Gross margin is 64.9% and operating margin is -3.6%, with a -2.0% net margin.

What is The Beauty Health Company's earnings per share?

The Beauty Health Company's diluted EPS over the trailing twelve months is $-0.16.

Where does The Beauty Health Company's income statement data come from?

Every line is extracted from The Beauty Health Company's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

The Beauty Health Company SKIN Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$296.12M-1.6%	$300.79M-0.4%	$301.92M-2.6%	$310.06M-3.8%	$322.47M-3.5%
Total cost of revenue	$103.9M-0.5%	$104.43M-1.7%	$106.25M-11.0%	$119.38M-14.7%	$139.96M-7.9%
Gross profit	$192.22M-2.1%	$196.36M+0.4%	$195.67M+2.6%	$190.69M+4.5%	$182.52M+0.1%
Gross margin	64.9%-0.4pp	65.3%+0.5pp	64.8%+3.3pp	61.5%+4.9pp	56.6%+2.1pp
Research and development	$5.73M+1.8%	$5.63M+8.9%	$5.17M+12.9%	$4.58M+2.1%	$4.49M-28.7%
Selling and marketing	$90.75M-3.0%	$93.59M-3.1%	$96.6M-6.5%	$103.29M-6.7%	$110.67M-6.5%
General and administrative	$106.33M-9.9%	$117.95M-3.3%	$122.02M-3.3%	$126.21M-3.0%	$130.17M+3.7%
Compensation and benefits	$13.43M-9.4%	$14.82M-13.3%	$17.09M-23.5%	$22.35M-5.1%	$23.54M-11.8%
Advertising	——	$6M-10.1%	$6.68M-9.2%	$7.35M-8.4%	$8.03M-7.8%
Depreciation and amortization	$17.37M+2.2%	$16.99M-4.2%	$17.74M+10.3%	$16.08M-9.3%	$17.73M-9.2%
Provision for credit losses	$1.87M-9.6%	$2.07M+6.9%	$1.93M-58.7%	$4.68M-10.4%	$5.22M+1.6%
Other operating expenses	$202.8M-6.6%	$217.17M-3.0%	$223.79M-4.4%	$234.08M-4.6%	$245.32M-1.9%
Total operating expenses	$202.8M-6.6%	$217.17M-3.0%	$223.79M-4.4%	$234.08M-4.6%	$245.32M-1.9%
Operating income	-$10.74M+48.8%	-$20.97M+25.4%	-$28.12M+35.2%	-$43.4M+30.9%	-$62.81M+7.3%
Operating margin	-3.6%+3.3pp	-7%+2.3pp	-9.3%+4.7pp	-14%+5.5pp	-19.5%+0.8pp
Interest expense	$23.17M+19.9%	$19.33M+25.4%	$15.42M+33.2%	$11.57M+17.1%	$9.88M-5.1%
Interest income	$7.41M-17.2%	$8.95M-7.3%	$9.66M-27.3%	$13.28M-7.2%	$14.32M-14.0%
Other income (expense), net	$19.92M+5.2%	$18.93M+0.2%	$18.9M+2.9%	$18.36M+4.7%	$17.54M-47.8%
Gain (loss) on extinguishment of debt	——	——	——	——	——
Income before income taxes	-$3.55M+40.2%	-$5.94M+53.8%	-$12.85M+30.7%	-$18.55M+50.4%	-$37.42M-26.6%
Income tax expense	$2.51M-30.0%	$3.58M+425%	-$1.1M-340%	$459K-58.2%	$1.1M+343%
Net income	-$6.05M+36.4%	-$9.52M+19.0%	-$11.75M+38.2%	-$19.01M+50.7%	-$38.52M-32.4%
Net margin	-2%+1.1pp	-3.2%+0.7pp	-3.9%+2.2pp	-6.1%+5.8pp	-11.9%-3.2pp
Basic earnings per share	-$0.05+37.5%	-$0.08+11.1%	-$0.09+40.0%	-$0.15+51.6%	-$0.31-29.2%
Weighted-average shares, diluted	534.4M+1.2%	528.1M-1.3%	534.8M+0.5%	531.9M-0.3%	533.6M-3.5%
Weighted-average shares, basic	507.1M+0.5%	504.4M+0.5%	501.9M+0.6%	499M+0.5%	496.7M+0.4%
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	$2.31M+46.9%	$1.57M-1.6%	$1.6M+7.8%	$1.48M+29.8%	$1.14M-39.8%
Share-based compensation expense related to employee stock plans	$13.43M-9.4%	$14.82M-13.3%	$17.09M-23.5%	$22.35M-5.1%	$23.54M-11.8%
Advertising costs	——	$6M-10.1%	$6.68M-9.2%	$7.35M-8.4%	$8.03M-7.8%
Accounts Receivable, Allowance for Credit Loss, Writeoff	——	$5.64M+18.4%	$4.77M+22.5%	$3.89M+29.0%	$3.02M+40.9%
Amortization Of Financing Costs	$3.86M+6.2%	$3.64M+6.7%	$3.41M+6.1%	$3.21M+1.9%	$3.15M-5.0%
Amortization of capitalized software and acquired intangible assets	$17.37M+2.2%	$16.99M-4.2%	$17.74M+10.3%	$16.08M-9.3%	$17.73M-9.2%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect	——	——	——	——	——
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$1.94M+51.5%	-$4M+59.2%	-$9.81M+39.8%	-$16.3M+59.5%	-$40.26M-21.9%
Federal	——	$146K+30.6%	$111.75K+44.2%	$77.5K+79.2%	$43.25K+381%
Foreign	——	$1.33M-23.9%	$1.75M-19.3%	$2.17M-16.1%	$2.58M-13.9%
Current State And Local Tax Expense Benefit	——	$224K+11.3%	$201.25K+12.7%	$178.5K+14.6%	$155.75K+17.1%
Deferred Foreign Income Tax Expense Benefit	——	$1.88M+268%	$510.5K+159%	-$858K+61.5%	-$2.23M+38.1%
Deferred and other income taxes	——	——	-$605K—	——	——
State	——	$0—	$0—	$0—	$0—
Defined Contribution Plan Cost Recognized	——	$2.3M-4.2%	$2.4M-4.0%	$2.5M-3.8%	$2.6M-3.7%
Depreciation	$2.56M-33.6%	$3.85M-17.4%	$4.66M-34.2%	$7.08M-21.6%	$9.02M-9.2%
Interest expense attributable to convertible notes	——	——	——	——	——
Effect of exchange rate changes on cash, cash equivalents and restricted cash	——	——	——	——	——
Change in fair value of warrants	——	——	——	——	——
Change in fair value of warrants	——	-$102K+57.1%	-$237.5K+36.3%	-$373K+26.6%	-$508.5K+21.0%
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate	——	——	——	——	——
Foreign operations	——	——	——	——	——
Other	——	-$0.12—	——	——	——
Share-based compensation	——	——	——	——	——
Officer compensation	——	$700K-6.8%	$751.25K-6.4%	$802.5K-6.0%	$853.75K-5.7%
Officer compensation	——	——	——	——	——
Changes in unrecognized tax benefits	——	——	——	——	——
Effective Income Tax Rate Reconciliation Tax Credits Research	——	——	——	——	——
Gain (Loss), Foreign Currency Transaction, before Tax	$3.11M-49.7%	$6.19M+261%	$1.72M-58.7%	$4.15M+384%	-$1.46M+68.5%
Foreign Currency Translation and Other Adjustments	$1.99M-36.4%	$3.12M+200%	$1.04M—	——	——
Income Loss From Continuing Operations Before Income Taxes Domestic	——	-$12.46M+24.1%	-$16.43M+19.5%	-$20.4M+16.3%	-$24.36M+14.0%
Income Loss From Continuing Operations Before Income Taxes Foreign	——	$6.52M+42.2%	$4.59M+73.0%	$2.65M+270%	$717.5K+159%
State taxes	——	$84K—	——	——	——
Income Tax Reconciliation Change In Enacted Tax Rate	——	——	——	——	——
Income Tax Reconciliation Foreign Income Tax Rate Differential	——	——	——	——	——
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	——	-$1.25M+49.9%	-$2.49M+33.3%	-$3.73M+25.0%	-$4.97M+20.0%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount	——	$729K—	——	——	——
Share-based compensation	——	$1.87M-30.4%	$2.69M-23.3%	$3.5M-18.9%	$4.32M-15.9%
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	——	——	——	——	——
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	——	$227K-21.5%	$289K-17.7%	$351K-15.0%	$413K-13.1%
Changes in unrecognized tax benefits	——	$208K—	——	——	——
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount	——	$108K-29.5%	$153.25K-22.8%	$198.5K-18.6%	$243.75K-15.7%
Accounts payable and other current liabilities	——	——	——	-$14.81M+48.4%	-$28.72M+34.4%
Increase (Decrease) in Accounts Receivable	——	——	——	——	-$18.91M+9.1%
Increase (Decrease) in Inventories	-$11.9M+24.7%	-$15.79M-95.4%	-$8.08M-56.6%	-$5.16M—	——
Increase in operating lease right of use asset	——	——	——	——	——
Increase (Decrease) in Other Operating Assets and Liabilities, Net	$6.79M-0.5%	$6.83M-15.1%	$8.04M-4.1%	$8.38M-11.3%	$9.45M+0.5%
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	——	——	-$16.45M-6.3%
Incremental Common Shares Attributable To Conversion Of Debt Securities	25.5M+16.5%	21.9M-29.7%	31.2M0.0%	31.2M-15.5%	36.9M-36.7%
Inventory Write Down	$7.32M+1.4%	$7.22M-19.6%	$8.98M-19.9%	$11.22M-50.9%	$22.84M-18.6%
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	-$195.58M-11.8%	-$174.93M+0.1%	-$175.18M-0.3%	-$174.59M-74.6%	-$99.97M+36.9%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$5.67M-9.8%	-$5.16M-11.2%	-$4.64M+17.8%	-$5.65M+7.9%	-$6.14M+9.7%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$28.94M-22.8%	$37.49M-3.3%	$38.76M—	——	——
Number of operating segments	——	——	——	——	——
Number of reportable segments	——	——	——	——	——
Number of reporting units	——	1—	——	——	——
Operating Lease Payments	——	$5.88M+3.3%	$5.69M+3.4%	$5.5M+3.6%	$5.31M+3.7%
Other Amortization Of Deferred Charges	$4.6M+1.9%	$4.51M+8.4%	$4.16M-7.9%	$4.52M+1.8%	$4.44M+5.7%
Foreign currency translation	$4.11M-25.5%	$5.52M+185%	$1.94M-28.3%	$2.7M+255%	-$1.74M+55.5%
Other income, net (Note 6)	$19.92M+5.2%	$18.93M+0.2%	$18.9M+2.9%	$18.36M+4.7%	$17.54M-47.8%
All other operating activities	——	——	——	$4.47M-63.4%	$12.21M-23.6%
Payment, Tax Withholding, Share-Based Payment Arrangement	$2.07M+31.5%	$1.57M-2.5%	$1.61M-1.0%	$1.63M+21.7%	$1.34M-31.6%
Payments to Acquire Intangible Assets	$5.19M+6.7%	$4.86M+10.3%	$4.41M-19.0%	$5.44M-4.3%	$5.68M-5.9%
Payments to Acquire Property, Plant, and Equipment	$482K+59.1%	$303K+27.3%	$238K+10.7%	$215K-53.0%	$457K-39.6%
Net additions (releases) charged to costs and expenses	$1.87M-9.6%	$2.07M+6.9%	$1.93M-58.7%	$4.68M-10.4%	$5.22M+1.6%
Repayments Of Convertible Debt	——	——	——	$18.37M-81.3%	$98.33M-37.0%
Revenue From Contract With Customer Excluding Assessed Tax	$296.12M-1.6%	$300.79M-0.4%	$301.92M-2.6%	$310.06M-3.8%	$322.47M-3.5%
Right Of Use Asset Obtained In Exchange For Operating Lease Liability	——	$2.36M-31.0%	$3.41M-23.7%	$4.47M-19.1%	$5.53M-16.1%
Stock-based compensation	$13.43M-9.4%	$14.82M-13.3%	$17.09M-23.5%	$22.35M-5.1%	$23.54M-11.8%
Granted (in shares)	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period	——	——	——	——	——
Options canceled (in dollars per share)	——	——	——	——	——
Granted (in shares)	——	——	——	——	——
Options forfeited/expired (in dollars per share)	——	——	——	——	——
Exercised (in shares)	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period	——	——	——	——	——
Syndeo program charges	——	——	——	——	——
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions	——	$0-100%	$13.5K-50.0%	$27K-33.3%	$40.5K-25.0%
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions	——	$121K-22.4%	$156K-18.3%	$191K-15.5%	$226K-13.4%
Additions for tax positions of prior years	——	$422K+33.3%	$316.5K+50.0%	$211K+100%	$105.5K—
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations	——	$0-100%	$29.25K-50.0%	$58.5K-33.3%	$87.75K-25.0%
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	——	$600K-14.3%	$700K-12.5%	$800K-11.1%	$900K-10.0%
Write-off of financing costs on extinguished debt	——	——	——	——	——
EBIT	-$10.74M+48.8%	-$20.97M+25.4%	-$28.12M+35.2%	-$43.4M+30.9%	-$62.81M+7.3%
EBITDA	$9.18M+7,215%	-$129K+97.7%	-$5.73M+71.7%	-$20.24M+43.9%	-$36.05M+5.9%
EBITDA	$9.18M+7,215%	-$129K+97.7%	-$5.73M+71.7%	-$20.24M+43.9%	-$36.05M+5.9%
EBITDA margin	3.1%+3.1pp	-0%+1.9pp	-1.9%+4.6pp	-6.5%+4.7pp	-11.2%+0.3pp
EBIT	-$10.74M+48.8%	-$20.97M+25.4%	-$28.12M+35.2%	-$43.4M+30.9%	-$62.81M+7.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about The Beauty Health Company.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is The Beauty Health Company's revenue?: The Beauty Health Company (SKIN) generated $296.1M in revenue over the trailing twelve months, down 8.2% year over year.
Is The Beauty Health Company profitable?: The Beauty Health Company is not currently profitable: it reported a net loss of $6.1M over the trailing twelve months, a -2.0% net margin.
What are The Beauty Health Company's profit margins?: Gross margin is 64.9% and operating margin is -3.6%, with a -2.0% net margin.
What is The Beauty Health Company's earnings per share?: The Beauty Health Company's diluted EPS over the trailing twelve months is $-0.16.
Where does The Beauty Health Company's income statement data come from?: Every line is extracted from The Beauty Health Company's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.